e-Drug3D

1525

CLOBAZAM


INN
CLOBAZAM

cas 22316-47-8
CLASS

NERVOUS SYSTEM
ANXIOLYTICS
ANTIEPILEPTIC
BENZODIAZEPINE DERIVATIVES
SEIZURES ASSOCIATED WITH LENNOX-GASTAUT SYNDROME
GABAA AGONIST

ROUTE (list)

ORAL

ATC code

N05BA09

PK parameters

F 100 PERCENT
VD 100 LITER
Cl 1.7 LITER / HOUR (EQN)
PPB 85 PERCENT
t1/2 39 HOUR

Solubility

SLIGHTLY SOLUBLE IN WATER


Target

TARGET GABAA RECEPTOR

DrugCentral

GABA-A receptor alpha-1,beta-2,gamma-2 UNIPROT P14867 GABRA1

Download SDF file 7-Chloro-1-methyl-5-phenyl-1H-1,5benzodiazepine-2,4(3H,5H)-dione

Formula:
C16H13ClN2O2

Calculated chemical properties:

MW 300.73
NB_atoms 21
XLogP 3.37
PSA 38.795
NB_HD 0
NB_HA 4
fsp3 0.12
Lipinski(0=no;1=yes) 1

FDA
NDA 202067 (pdf not found) INN (CLOBAZAM) ONFI (LUNDBECK PHARMS LLC) APPROVAL= AP YEAR= 2011
NDA 203993 (pdf not found) INN (CLOBAZAM) ONFI (LUNDBECK PHARMS LLC) APPROVAL= AP YEAR= 2012
NDA 208785 (pdf not found) INN (CLOBAZAM) CLOBAZAM (HIKMA) APPROVAL= AP YEAR= 2018 DISCONTINUED
NDA 208819 (pdf not found) INN (CLOBAZAM) CLOBAZAM (BIONPHARMA) APPROVAL= AP YEAR= 2018
NDA 208825 (pdf not found) INN (CLOBAZAM) CLOBAZAM (BIONPHARMA) APPROVAL= AP YEAR= 2018
NDA 209308 (pdf not found) INN (CLOBAZAM) CLOBAZAM (ESJAY PHARMA) APPROVAL= AP YEAR= 2018 DISCONTINUED
NDA 209440 (pdf not found) INN (CLOBAZAM) CLOBAZAM (TARO) APPROVAL= AP YEAR= 2018 DISCONTINUED
NDA 209687 (pdf not found) INN (CLOBAZAM) CLOBAZAM (UPSHER SMITH LABS) APPROVAL= AP YEAR= 2018
NDA 209715 (pdf not found) INN (CLOBAZAM) CLOBAZAM (HIKMA) APPROVAL= AP YEAR= 2018 DISCONTINUED
NDA 209718 (pdf not found) INN (CLOBAZAM) CLOBAZAM (AMNEAL PHARMS CO) APPROVAL= AP YEAR= 2018
NDA 209795 (pdf not found) INN (CLOBAZAM) CLOBAZAM (HETERO LABS LTD III) APPROVAL= AP YEAR= 2018
NDA 209808 (pdf not found) INN (CLOBAZAM) CLOBAZAM (PIRAMAL) APPROVAL= AP YEAR= 2018
NDA 210039 (pdf not found) INN (CLOBAZAM) CLOBAZAM (AMNEAL) APPROVAL= AP YEAR= 2018
NDA 210545 (pdf not found) INN (CLOBAZAM) CLOBAZAM (LUPIN LTD) APPROVAL= AP YEAR= 2018
NDA 210546 (pdf not found) INN (CLOBAZAM) CLOBAZAM (LUPIN LTD) APPROVAL= AP YEAR= 2018
NDA 210569 (pdf not found) INN (CLOBAZAM) CLOBAZAM (UPSHER SMITH LABS) APPROVAL= AP YEAR= 2018 DISCONTINUED
NDA 210833 (pdf not found) INN (CLOBAZAM) SYMPAZAN (ASSERTIO SPECLTY) APPROVAL= AP YEAR= 2018
NDA 211259 (pdf not found) INN (CLOBAZAM) CLOBAZAM (PHARMOBEDIENT) APPROVAL= AP YEAR= 2018 DISCONTINUED
NDA 211449 (pdf not found) INN (CLOBAZAM) CLOBAZAM (ZYDUS PHARMS) APPROVAL= AP YEAR= 2018
NDA 210978 (pdf not found) INN (CLOBAZAM) CLOBAZAM (TARO) APPROVAL= AP YEAR= 2019
NDA 211711 (pdf not found) INN (CLOBAZAM) CLOBAZAM (MICRO LABS) APPROVAL= AP YEAR= 2019
NDA 212398 (pdf not found) INN (CLOBAZAM) CLOBAZAM (ACCORD HLTHCARE) APPROVAL= AP YEAR= 2019 DISCONTINUED
NDA 210746 (pdf not found) INN (CLOBAZAM) CLOBAZAM (VISTAPHARM LLC) APPROVAL= AP YEAR= 2019 DISCONTINUED
NDA 212092 (pdf not found) INN (CLOBAZAM) CLOBAZAM (CHARTWELL MOLECULAR) APPROVAL= AP YEAR= 2019 DISCONTINUED
NDA 212714 (pdf not found) INN (CLOBAZAM) CLOBAZAM (ALKEM LABS LTD) APPROVAL= AP YEAR= 2019
NDA 209796 (pdf not found) INN (CLOBAZAM) CLOBAZAM (HETERO LABS LTD III) APPROVAL= AP YEAR= 2020
NDA 209853 (pdf not found) INN (CLOBAZAM) CLOBAZAM (APOTEX) APPROVAL= AP YEAR= 2020 DISCONTINUED
NDA 211032 (pdf not found) INN (CLOBAZAM) CLOBAZAM (TEVA PHARMS USA) APPROVAL= AP YEAR= 2020 DISCONTINUED
NDA 213110 (pdf not found) INN (CLOBAZAM) CLOBAZAM (CHARTWELL MOLECULAR) APPROVAL= AP YEAR= 2020
NDA 211959 (pdf not found) INN (CLOBAZAM) CLOBAZAM (ANDA REPOSITORY) APPROVAL= AP YEAR= 2020 DISCONTINUED
NDA 213039 (pdf not found) INN (CLOBAZAM) CLOBAZAM (ALKEM LABS LTD) APPROVAL= AP YEAR= 2021
NDA 213404 (pdf not found) INN (CLOBAZAM) CLOBAZAM (MSN) APPROVAL= AP YEAR= 2021
NDA 214404 (pdf not found) INN (CLOBAZAM) CLOBAZAM (AUROBINDO PHARMA LTD) APPROVAL= AP YEAR= 2022
NDA 216008 (pdf not found) INN (CLOBAZAM) CLOBAZAM (ACCORD HLTHCARE) APPROVAL= AP YEAR= 2022 DISCONTINUED

Other links:

PubChem
ChemicalProbes

U.S. repository of Clinical Trials

VigiAccess
SIDER side effects

ChemSynthesis
Patent@SureChEMBL